CNS Pharmaceuticals, Inc.
CNSP
$1.12
-$0.005-0.44%
NASDAQ
12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
---|---|---|---|---|---|
Total Cash And Short-Term Investments | -7.34% | 367.49% | 82.97% | 48.57% | -39.67% |
Total Receivables | -- | -- | -- | -- | -- |
Inventory | -- | -- | -- | -- | -- |
Prepaid Expenses | 233.51% | -39.10% | -18.95% | -6.37% | -27.14% |
Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
Other Current Assets | -23.42% | 60.12% | -- | -- | -- |
Total Current Assets | 17.20% | 244.37% | 33.98% | 0.63% | -22.82% |
|
|||||
Total Current Assets | 17.20% | 244.37% | 33.98% | 0.63% | -22.82% |
Net Property, Plant & Equipment | 114.29% | -22.22% | -16.28% | -12.24% | 40.00% |
Long-term Investments | -- | -- | -- | -- | -- |
Goodwill | -- | -- | -- | -- | -- |
Total Other Intangibles | -- | -- | -- | -- | -- |
Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
Total Other Assets | 97.83% | -94.26% | 479.20% | -47.23% | -60.11% |
Total Assets | 17.43% | 200.06% | 48.67% | -2.35% | -26.94% |
|
|||||
Total Accounts Payable | -45.39% | -39.37% | 12.95% | 0.79% | 44.83% |
Total Accrued Expenses | -- | -- | -- | -- | -- |
Short-term Debt | 945.19% | -74.68% | -42.19% | -29.16% | 617.90% |
Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
Total Other Current Liabilities | -- | -- | -- | -- | -- |
Total Current Liabilities | -37.78% | -40.01% | 11.02% | -0.68% | 50.73% |
|
|||||
Total Current Liabilities | -37.78% | -40.01% | 11.02% | -0.68% | 50.73% |
Long-Term Debt | -- | -- | -- | -- | -- |
Short-term Debt | 945.19% | -74.68% | -42.19% | -29.16% | 617.90% |
Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Non Current | -- | -- | -- | -- | -- |
Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
Total Other Liabilities | -- | -- | -- | -- | -- |
Total Liabilities | -37.78% | -40.01% | 11.02% | -0.68% | 50.73% |
|
|||||
Common Stock & APIC | 7.09% | 18.57% | 3.88% | 5.44% | 4.30% |
Retained Earnings | -3.91% | -7.41% | -3.46% | -5.10% | -8.37% |
Treasury Stock & Other | -- | -- | -- | -- | -- |
Total Common Equity | 84.25% | 178.08% | 3.09% | 0.04% | -154.60% |
|
|||||
Preferred Stock Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Convertible | -- | -- | -- | -- | -- |
Preferred Stock, Others | -- | -- | -- | -- | -- |
Total Preferred Equity | -- | -- | -- | -- | -- |
|
|||||
Total Common Equity | 84.25% | 178.08% | 3.09% | 0.04% | -154.60% |
Total Preferred Equity | -- | -- | -- | -- | -- |
Total Minority Interest | -- | -- | -- | -- | -- |
Total Equity | 84.25% | 178.08% | 3.09% | 0.04% | -154.60% |
|